![]() |
|
|
Vol. 31, Issue 4, 367-372, April 2003
Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
| |
Abstract |
|---|
|
|
|---|
The reductive metabolism of 2-nitrofluorene, a carcinogenic air
pollutant, in rat skin microsomes and cytosol was investigated. 2-Nitrofluorene was reduced to the corresponding amine by the microsomes with NADPH and by the cytosol with 2-hydroxypyrimidine or
4-hydroxypyrimidine under anaerobic conditions. The cytosolic activity
was much higher than that of skin microsomes. The 2- or
4-hydroxypyrimidine-linked nitroreductase activity was inhibited by
oxypurinol and (+/
)-8-(3-methoxy-4-phenylsulfinylphenyl)
pyrazolo[1,5-a]-1,3,5-triazine-4(1H)-one (BOF-4272), inhibitors of xanthine oxidase, but not by menadione, chlorpromazine and isovanillin, inhibitors of aldehyde oxidase. When
skin cytosol was applied to a DEAE-cellulose column, the fractions
containing xanthine oxidase exhibited a marked
2-hydroxypyrimidine-linked nitroreductase activity. In contrast, the
aldehyde oxidase fraction showed little activity. Nitroreductase
fractions obtained by ion exchange chromatography showed a band in
Western blotting analysis using anti-rat xanthine oxidase. Moreover,
the xanthine oxidase fraction exhibited a significant nitroreductase
activity in the presence of 2-hydroxypyrimidine, 4-hydroxypyrimidine or
hypoxanthine, and these activities were inhibited by inhibitors of
xanthine oxidase. These results indicated that reduction of
2-nitrofluorene in the skin was mainly catalyzed by xanthine oxidase.
| |
Introduction |
|---|
|
|
|---|
Nitrated
polycyclic aromatic hydrocarbons (nitro-PAHs1),
which are found in particulate emissions from diesel engines, in
exhaust from kerosene heaters, in urban air, and in river sediments,
are generated by the incomplete combustion of fossil fuels and
photochemical reactions (El-Bayoumy et al., 1982
; Rosenkranz and
Mermelstein, 1983
). They are potentially mutagenic and carcinogenic to
humans through inhalation, ingestion, and skin contact (IARC, 1989
; Fu, 1990
; Purohit and Basu, 2000
). 2-Nitrofluorene is one of the nitro-PAHs and is found in ambient air together with other nitro-PAHs (Beije and
Möller, 1988
). It has been investigated in a large number of
studies as a model substance for nitro-PAHs. The International Agency
for Research on Cancer has classified 2-nitrofluorene as carcinogenic
in experimental animals and possibly carcinogenic in humans (IARC,
1989
).
The mechanism of genotoxicity is thought to involve metabolic reduction
of these nitro-PAHs, so that reduction of the nitro group is considered
a key metabolic reaction in the activation of 2-nitrofluorene to
mutagens (McCoy et al., 1981
; Vance et al., 1987
) and ultimate
carcinogen (Beije and Möller, 1988
). In our previous study, it
was demonstrated that 2-nitrofluorene was mainly metabolized to
2-aminofluorene and its acylated metabolites in rat and dog (Ueda et
al., 2001
). Möller et al. (1987)
also examined the in vivo
metabolism of 2-nitrofluorene in rats and identified two metabolites,
7-hydroxy-2-acetylaminofluorene and 5-hydroxy-2-acetylaminofluorene; they speculated that 2-nitrofluorene was reduced to 2-aminofluorene, which was acetylated to 2-acetylaminofluorene and further metabolized via the known 2-acetylaminofluorene metabolic pathway. Therefore, it is
considered that nitroreduction plays the key role in the metabolism of
2-nitrofluorene in vivo. Reduction of nitro-PAHs and aromatic nitro
compounds proceeds with microsomal and cytosolic fractions of mammalian
liver. Previous studies showed that cytochrome P450 systems, xanthine
oxidase and/or aldehyde oxidase are involved in the reduction of
1-nitropyrene, 4-nitrobiphenyl, 1-nitronaphthalene, 2-nitrofluorene,
and 9-hydroxy-2-nitrofluorene to the corresponding amines (Poirier and
Weisburger, 1974
; El-Bayoumy et al., 1982
; El-Bayoumy and Hecht, 1983
;
Kitamura et al., 1983
; Saito et al., 1984
). However, little is known
about nitroreduction of nitro-PAHs in extrahepatic tissues, for example
skin, that are potential targets for environmental contaminants.
Skin is constantly exposed to a variety of environmental chemicals,
cosmetics, and drugs. It is not merely a passive structural barrier
between the body and environmental chemicals but also may be important
site of metabolism. In recent years, although cutaneous metabolic
reactions with skin preparations, tissue-cultured skin, and slices have
been well studied, most of the work has dealt with oxidative reactions
catalyzed by cytochrome P450 (Kao and Carver, 1990
; Jugert et al.,
1994
; Ahmad et al., 1996
; Cotovio et al., 1996
) and alcohol
dehydrogenase (Boehnlein et al., 1994
); conjugative reactions catalyzed
by glutathione S-transferase (Mukhtar and Bickers, 1981
;
Agarwal et al., 1992
), UDP-glucuronosyltransferase (Moloney et al.,
1982
), and sulfotransferase (Wong et al., 1993
); and hydrolytic
reactions catalyzed by esterases (McCracken et al., 1993
). Little is
known about reductive reactions in skin.
In the present study, in vitro metabolism in rat skin was examined, focusing on nitroreduction of 2-nitrofluorene, and it was demonstrated that xanthine oxidase plays the major role in the nitroreduction of 2-nitrofluorene in the skin.
| |
Materials and Methods |
|---|
|
|
|---|
Materials.
2-Nitrofluorene, 2-aminofluorene, 2-hydroxypyrimidine,
benzaldehyde, 1-methylxanthine, and xanthine were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Menadione, oxypurinol, chlorpromazine, 4-hydroxypyrimidine, phenylmethylsulfonyl
fluoride, N1-methylnicotinamide and
isovanillin were from Wako Pure Chemical Industries, Ltd. (Osaka,
Japan). BOF-4272 was obtained from Otsuka Pharmaceutical Factory, Inc.
(Tokushima, Japan). Hypoxanthine and bovine milk xanthine oxidase
(14.43 U/ml, 10.5 mg/ml) were purchased from Calbiochem (San Diego,
CA). Anti-rat aldehyde oxidase rabbit serum was prepared by the
method of Sugihara et al. (1995)
. Anti-rat xanthine oxidase rabbit
antibody was kindly provided by Dr. T. Nishino (Nippon Medical School,
Tokyo, Japan). Other chemicals used were of the highest grade
commercially available.
Preparations of Tissue Microsomes and Cytosol.
Male Sea/Sprague Dawley rats (5 weeks old) from Seiwa Experimental
Animals, Ltd. (Fukuoka, Japan) were used. The animals were exsanguinated, and the back of each animal was immediately shaved with
an electric clipper over an area of approximately 4 × 5 cm. The
skin was excised, and the sheets were placed with the epidermal side
down on an ice-cooled glass plate, and subcutaneous tissues were
scraped off with scissors. Scraped sheets of skin free from fat were
cut into pieces with scissors and mixed with three volumes of 0.1 M
K,Na-phosphate buffer (pH 7.4) containing 0.1 mM dithiothreitol, 0.1 mM
phenylmethylsulfonyl fluoride, 0.1 mM EDTA and 0.1 mM ethylene glycol bis (
-aminoethyl ether)-N,N,N',N'-tetraacetic acid
(buffer A), and then homogenized with a Polytron tissue homogenizer
(Kinematica GmbH, Zurich, Switzerland). Microsomes and cytosol were
obtained from the homogenate by successive centrifugation at
9000g for 20 min and at 105,000g for 60 min. The
microsomal fraction was washed by resuspension in the 0.1 M
K,Na-phosphate buffer (pH 7.4) containing 0.1 mM EDTA, and
recentrifugation at 105,000g for 60 min. The
105,000g pellet (microsomal fraction) was resuspended in the
same buffer. The cytosol fraction was dialyzed against 400 volumes of
buffer A for 18 h. The microsomes and cytosol were stored at
80°C. Protein was determined by the method of Lowry et al. (1951)
with bovine serum albumin as a standard.
Assays of Nitroreductase Activity. The incubation mixture consisted of 0.1 µmol of 2-nitrofluorene (the concentration was chosen on the basis of the Km value of 10.1 µM and the accuracy of the assay), 0.5 µmol of an electron donor, and a skin preparation or 0.07 U of milk xanthine oxidase in a final volume of 1 ml of 0.1 M K,Na-phosphate buffer (pH 7.4). The incubation was performed at 37°C for 30 min under an atmosphere of nitrogen or carbon monoxide using a Thunberg tube. The protein concentration used in assays was 2 mg/ml. In some cases, incubation was also performed in the presence of 10 µM menadione, or 100 µM chlorpromazine, isovanillin or oxypurinol, or 20 µg/ml BOF-4272. Control incubation containing no substrate and no enzyme was performed in the same manner as normal incubation. After incubation, 50 µg of phenacetin was added to the mixture as an internal standard, and then the mixture was extracted with 7 ml of ethyl acetate. The extract was evaporated to dryness in vacuo and the residue was subjected to high-performance liquid chromatography (HPLC).
HPLC. HPLC was performed in an LC-10ADVP (Shimadzu Co., Ltd., Kyoto, Japan) chromatograph fitted with a 250 × 4.6 mm column of CAPCELL PAK UG120 (Shiseido Co., Ltd., Tokyo, Japan). For the determination of 2-aminofluorene, the column was operated at a flow rate of 0.7 ml/min of CH3CN/H2O (6:4) at 40°C, using phenacetin as an internal standard, with the detector set at 280 nm. Retention times of authentic phenacetin (an internal standard), 2-aminofluorene, and 2-nitrofluorene were 5.1, 8.7, and 18.5 min, respectively.
Assays of Xanthine Oxidase Activity. The assay was performed by measuring the increase in absorbance at 292 nm, which accompanies the oxidation of xanthine to uric acid.
Western Blot Analysis. Rat skin cytosol and DEAE-fractions containing 5 µg of protein were separated by 7.5% SDS-polyacrylamide gel electrophoresis, and proteins were transferred onto a polyvinylidene fluoride membrane (0.2 mm; Bio-Rad, Hercules, CA) using semidry electrotransfer in glycine, SDS (0.1%), and methanol (5%). The membrane was blocked for 60 min with blot buffer [20 mM Tris-HCl buffer (pH 8.0) containing 5% (w/v) nonfat milk] at room temperature, then briefly washed with the blot buffer and incubated overnight after addition of anti-rat aldehyde oxidase rabbit serum (1 in 100 dilution) or anti-rat xanthine oxidase rabbit serum (1 in 200 dilution). The membrane was washed four times with the blot buffer, incubated with goat anti-rabbit IgG horseradish peroxidase (Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan) (1 in 2000 dilution) for 2 h at room temperature, and then washed four times with Tris-buffered saline (25 mM Tris-HCl, 0.5 M NaCl, pH 7.5). Development was performed in Tris-buffered saline containing 0.06% diaminobenzidine hydrochloride and 0.036% H2O2 for about 5 min.
DEAE-Cellulose Column Chromatography.
The skin cytosolic fraction was subjected to ammonium sulfate
fractionation, and proteins that precipitated between 30 and 60%
ammonium sulfate saturation were collected. The precipitate was
dissolved in buffer A and dialyzed against 100 volumes of 10-fold
diluted buffer A for 12 h. The dialyzed solution was adsorbed on a
column (1.5 × 12 cm) of DE-52, which was equilibrated with buffer
A. The column was washed with 50 ml of buffer A and eluted with a
100-ml linear gradient of 0 to 0.3 M sodium chloride in buffer A. The
fractions collected were assayed for nitroreductase activity toward
2-nitrofluorene in the presence of 2-hydroxypyrimidine or hypoxanthine,
and the active fractions were pooled and stored at
80°C.
| |
Results |
|---|
|
|
|---|
Metabolism of 2-Nitrofluorene by Rat Skin Preparations. The in vitro metabolism of 2-nitrofluorene by rat skin preparations was examined. When 2-nitrofluorene was anaerobically incubated with skin microsomes plus NADPH or cytosol plus 2-hydroxypyrimidine, a major metabolite was detected in HPLC chromatograms of the extracts of these incubation mixtures (Fig. 1). In the case of boiled skin preparations, the metabolite was not detected. The metabolite was identified as 2-aminofluorene by comparison of its HPLC, and UV and mass spectral comparison with authentic 2-aminofluorene (data not shown).
|
|
|
DEAE Column Chromatography of Skin Cytosol. When the skin cytosol was fractionated with ammonium sulfate as described under Materials and Methods, the nitroreductase activity was exclusively recovered between 30 and 60% ammonium sulfate saturation (data not shown). Furthermore, the ammonium sulfate precipitate was chromatographed on a DEAE-cellulose column. As shown in Fig. 4, 2-hydroxypyrimidine- and hypoxanthine-linked nitroreductases were coeluted with xanthine oxidase (fraction I; fraction 33-38). However, 2-hydroxypyrimidine-linked nitroreductase was also eluted in another fraction (fraction II; fraction 42-49).
|
Western Blot Analysis of Rat Skin Aldehyde Oxidase and Xanthine Oxidase. Fractions I and II were subjected to Western blot analysis. The primary antibodies used to probe the blots were rabbit anti-rat aldehyde oxidase and rabbit anti-rat xanthine oxidase antisera. As shown in Fig. 5, rabbit anti-rat xanthine oxidase antiserum reacted with skin cytosol and strongly reacted with fraction I, indicating that these bands correspond to xanthine oxidase. However, no band was detected from fraction II. On the other hand, rabbit anti-rat aldehyde oxidase antiserum reacted with skin cytosol, and a faint band was detectable in fraction II, but not in fraction I. These facts suggest that nitroreductase activity toward 2-nitrofluorene is exhibited mainly by xanthine oxidase and slightly by aldehyde oxidase.
|
Metabolism of 2-Nitrofluorene by DEAE Column Chromatography Fractions. Fraction I exhibited significant nitroreductase activity in the presence of 2-hydroxypyrimidine, 4-hydroxypyrimidine, or hypoxanthine. However, N1-methylnicotinamide and benzaldehyde supported little activity. The full activities with 2-hydroxypyrimidine and 4-hydroxypyrimidine were approximately 9-fold and 45-fold higher than those of skin cytosol, respectively. The 2-hydroxypyrimidine-linked nitroreductase activity of fraction I was inhibited by oxypurinol and BOF-4272 but not by menadione, chlorpromazine, or isovanillin (Fig. 6). Hypoxanthine-linked activity was also inhibited by oxypurinol and BOF-4272. On the other hand, the nitroreductase activity of fraction II was also enhanced by addition of 2-hydroxypyrimidine and 4-hydroxypyrimidine but to a much lesser extent than in the case of fraction I. The 2-hydroxypyrimidine- and 4-hydroxypyrimidine-linked nitroreductase activities were inhibited by menadione (data not shown). These results confirmed that the nitroreductase activities in fraction I and II were due to xanthine oxidase and aldehyde oxidase, respectively. Fraction I accounted for the majority of the activity.
|
| |
Discussion |
|---|
|
|
|---|
There is no conclusive evidence that 2-nitrofluorene in ambient
air is carcinogenic to human skin. However, El-Bayoumy et al. (1982)
reported that 3-nitropyrene and 6-nitrochrysene induced skin tumors in
laboratory animals. In rat, 2-aminofluorene induced skin tumors after
dermal application (Morris et al., 1950
). 2-Nitrofluorene lacked
initiating capacity in a mouse skin two-stage carcinogenesis system,
and nitroreductase activity toward nitro-PAH in mouse skin was very low
(Möller et al., 1993
). This suggests that 2-nitrofluorene may be
carcinogenic to skin, but this nitro-PAH is not activated by
nitroreduction in mouse skin. The reductive metabolites may be more
reactive electrophiles, which react with nucleic acid to produce
adducts. Our findings suggest that 2-nitrofluorene is carcinogenic
after nitroreduction to 2-aminofluorene in rats. On the other hand,
2-nitrofluorene may be activated by ultraviolet radiation to various
reactive intermediates that can bind to RNA and protein (Wierckx et
al., 1992
). Furthermore, Asokan et al. (1986)
reported that the skin is
a major target tissue of airborne nitroarenes. Bus drivers and tramway
employees were at increased risk of developing skin cancer
(Soll-Johanning et al., 1998
), and the incidence of skin cancer was
significantly elevated among bus drivers in Denmark (Netterstrøm,
1988
). These results indicate that numerous environmental chemicals,
including nitro-PAHs, may induce skin damage.
In the present study, it has been demonstrated that 2-nitrofluorene is
metabolized to 2-aminofluorene in rat skin preparations. In a previous
study, nitro-PAHs were metabolized to the corresponding amines by
reconstituted cytochrome P450 (Saito et al., 1984
). Our previous
studies showed that rabbit liver microsomes and cytosol generated
2-nitrofluorene reductive metabolites, hydroxylamine and amine, and
provided evidence that aldehyde oxidase functions as a major liver
enzyme responsible for 2-nitrofluorene reduction (Tatsumi et al.,
1986
). 1-Nitropyrene and 3-nitrofluoranthene were transformed to
reductive metabolites by xanthine oxidase in animal livers (Bauer and
Howard, 1990
). Therefore, it was supposed that several enzymes catalyze
the nitroreduction of nitro-PAHs. In the present study, nitroreductase
activity in skin cytosol was greater than that of microsomes and was
catalyzed mainly by xanthine oxidase. In mammary gland, cytosolic
nitroreductase activity toward 9-oxo-2-nitrofluorene was supported by
addition of hypoxanthine and
N1-methylnicotinamide, and the
activity was not inhibited by menadione (Ritter et al., 2000
). However,
our findings suggest that the nitroreduction of nitro-PAHs in mammary
gland also involves xanthine oxidase. 2-Nitro-4-aminoaniline and
3-nitro-4-hydroxyaniline, hair dye constituents, were mutagenic in
mammalian cells (Van Duuren, 1980
). In the skin, these chemicals may be
nitroreduced by xanthine oxidase, and such reduction would play an
important role in their toxicity. Furthermore, xanthine oxidase is
known to produce toxic superoxide anions, which are implicated as a possible mediator of tissue damage. Reactive oxygen species generated by xanthine oxidase are thought to cause lipid peroxidation,
inflammation, and symptoms of aging in the skin.
In the current study, the cytosolic nitroreductase activity was enhanced by addition of 2-hydroxypyrimidine and 4-hydroxypyrimidine, which are electron donors to aldehyde oxidase. The electron donor requirements of xanthine oxidase in rat skin seem contradictory. However, the 2-hydroxypyrimidine- and 4-hydroxypyrimidine-linked nitroreductase activities were not inhibited by inhibitors of aldehyde oxidase but were inhibited by inhibitors of xanthine oxidase. In addition, the requirements of 2-hydroxypyrimidine and 4-hydroxypyrimidine, and the susceptibility to xanthine oxidase inhibitors of commercial bovine milk xanthine oxidase, are consistent with the involvement of skin xanthine oxidase. The results of Western blotting analysis using anti-rat xanthine oxidase also supported the involvement of xanthine oxidase, but not aldehyde oxidase, in the nitroreduction. These experiments are consistent with the idea that 2-hydroxypyrimidine and 4-hydroxypyrimidine also function as electron donors of xanthine oxidase and that the nitroreduction by rat skin cytosol mainly involves xanthine oxidase but not aldehyde oxidase (Fig. 7).
|
The findings of this and other studies suggest that many xenobiotics and endogenous compounds as well as aromatic nitro compounds, might be metabolized in skin. When various drugs, cosmetics, toiletries, industrial chemicals, agricultural chemicals, and detergents come into contact with the skin, metabolites produced in the skin may cause irritation, sensitization, cytotoxicity, mutagenicity, or carcinogenicity.
| |
Acknowledgments |
|---|
We thank Dr. Takeshi Nishino, Nippon Medical School, who provided anti-rat xanthine oxidase rabbit antibody. We also thank Dr. Shinsaku Naito, Otsuka Pharmaceutical Factory, Inc., who provided BOF-4272.
| |
Footnotes |
|---|
Received September 23, 2002; accepted December 18, 2002.
This work was supported by Grant-in-Aid for Scientific Research on Priority Area (13027256) from the Japanese Ministry of Education, Science, Sports and Culture, and Grant-in-Aid for Scientific Research (C13672343) from Japan Society for the Promotion of Science.
Address correspondence to: Dr. Shigeyuki Kitamura, Graduate School of Biomedical Sciences, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima, 734-8551, Japan. E-mail address: skitamu{at}hiroshima-u.ac.jp
| |
Abbreviations |
|---|
Abbreviations used are:
PAHs, polycyclic
aromatic hydrocarbons;
BOF-4272, (+/
)-8-(3-methoxy-4-phenylsulfinylphenyl)
pyrazolo[1,5-a]-1,3,5-triazine-4(1H)-one;
HPLC, high-performance liquid chromatography.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
O. Ueda, K. Sugihara, S. Ohta, and S. Kitamura INVOLVEMENT OF MOLYBDENUM HYDROXYLASES IN REDUCTIVE METABOLISM OF NITRO POLYCYCLIC AROMATIC HYDROCARBONS IN MAMMALIAN SKIN Drug Metab. Dispos., September 1, 2005; 33(9): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||